Physician profile
Michael N Brown
NPI 1497775670
$2,703.60
in general payments reported to CMS, 2019-2025
41 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $108 · 2021: $588 · 2022: $584 · 2023: $451 · 2024: $258 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,091.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $805.50 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $178.15 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Abbvie INC. | $166.11 | 2021-2024 | Vraylar |
| Pfizer INC. | $154.33 | 2019-2025 | |
| Amgen INC. | $128.61 | 2019-2024 | Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.43 | 2021-2024 | Xifaxan |
| Sanofi-Aventis U.S. LLC | $98.35 | 2019-2023 | |
| Amarin Pharma, INC. | $92.56 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $76.52 | 2021 | |
| Novartis Pharmaceuticals Corporation | $74.88 | 2021-2023 | |
| Dexcom, INC. | $73.92 | 2021-2025 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $73.84 | 2023-2025 | Gemtesa |
| Takeda Pharmaceuticals U.S.A., INC. | $61.60 | 2021-2022 | |
| Exact Sciences Corporation | $59.13 | 2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $55.66 | 2019-2023 | Farxiga |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.